Browsing Tag
mFlusiva
2 posts
Moderna proposes $2bn zero-coupon notes as oncology success reshapes capital strategy
Moderna plans a $2 billion private placement of zero-regular-interest convertible notes due 2032, with a possible additional $300 million and capped-call protection designed to reduce dilution as the company prepares for increased oncology investment.
Moderna rallies into a landmark FDA advisory vote on its mRNA seasonal flu vaccine
Moderna (MRNA) rallies as an FDA advisory committee weighs its mRNA seasonal flu vaccine mFlusiva, the first such vote, with a decision due August 5. Full analysis.